Research made by Tang et al. suggested that miR‐133a‐3p can block PI3K/AKT signaling by targeting MET, EGFR, IGF1R and FGFR1 and other cytokine receptors in pancreatic cancer to inhibit bone metastasis of pancreatic cancer.25 This evidence concerns the gene EGFR and pancreatic neoplasm.